文献速递多重用药衰弱、肌少症与跌倒

老年驾驶员机动车事故前后可能损害驾驶能力药物的负担变化

Changes in the burden of medications that may impair driving among older adults before and after a motor vehicle crash.
PubMed 文献 · J Am Geriatr Soc · 2023-10-31

该观察性研究纳入2008至2017年新泽西州124954例次≥67岁Medicare按服务收费受益人的警报机动车事故,分析事故前后120天内36类可能损害驾驶能力(PDI)药物的使用变化。事故前后PDI药物类数中位数均为2类,20.3%净增、15.9%净减、63.8%无净变化。停用最多的是阿片类、抗组胺药和噻嗪类利尿剂,新启用最多的是阿片类、骨骼肌松弛剂和苯二氮䓬类。

要点

  • 事故前后PDI药物类数中位数均为2类,多数人无净变化。
  • 净增PDI药物者(20.3%)多于净减者(15.9%)。
  • 事故后新启用最多的为阿片类(8.3%)、骨骼肌松弛剂(2.2%)、苯二氮䓬类(2.1%)。

核心结论

  • 多数涉及事故的老年人事故前后均暴露于多种PDI药物,且净增者比例高于净减者。
  • 临床医生在事故后未停用PDI药物的原因尚待阐明。

研究设计与样本

  • 观察性研究,纳入2008至2017年新泽西州警报机动车事故中作为驾驶员的≥67岁Medicare按服务收费受益人。
  • 以「人-事故」为单位分析,共124954例次,平均(SD)年龄76.0(6.5)岁,女性51.3%,非西班牙裔白人83.9%。
  • 分析事故前120天与后120天内36类PDI药物的使用。

主要发现

  • PDI药物类数中位数(Q1,Q3)事故前后均为2(1,4)。
  • 事故后20.3%净增、15.9%净减、63.8%无净变化。
  • 停用最多的PDI药物类为阿片类6.2%、抗组胺药2.1%、噻嗪类利尿剂1.7%。
  • 新启用最多的为阿片类8.3%、骨骼肌松弛剂2.2%、苯二氮䓬类2.1%。

关键数值与推荐

  • PDI药物涵盖36个药物类。
  • 观察窗口为事故前120天与事故后120天。

临床怎么用

  • 对发生机动车事故的老年驾驶员应系统复核PDI药物清单,关注阿片类、苯二氮䓬类、骨骼肌松弛剂等新启用药物。
  • 事故后用药调整不应仅停留在停药,还需评估净增PDI药物的原因并优先处理可修改风险。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medications are one of the most easily modifiable risk factors for motor vehicle crashes (MVCs) among older adults, yet limited information exists on how the use of potentially driver-impairing (PDI) medications changes following an MVC. Therefore, we examined the number and types of PDI medication classes dispensed before and after an MVC. METHODS: This observational study included Medicare fee-for-service beneficiaries aged ≥67 years who were involved in a police-reported MVC in New Jersey as a driver between 2008 and 2017. Analyses were conducted at the "person-crash" level because participants could be involved in more than one MVC. We examined the use of 36 PDI medication classes in the 120 days before and 120 days after MVC. We described the number and prevalence of PDI medication classes in the pre-MVC and post-MVC periods as well as the most common PDI medication classes started and stopped following the MVC. RESULTS: Among 124,954 person-crashes, the mean (SD) age was 76.0 (6.5) years, 51.3% were female, and 83.9% were non-Hispanic White. The median (Q1 , Q3 ) number of PDI medication classes was 2 (1, 4) in both the pre-MVC and post-MVC periods. Overall, 20.3% had a net increase, 15.9% had a net decrease, and 63.8% had no net change in the number of PDI medication classes after MVC. Opioids, antihistamines, and thiazide diuretics were the top PDI medication classes stopped following MVC, at incidences of 6.2%, 2.1%, and 1.7%, respectively. The top medication classes started were opioids (8.3%), skeletal muscle relaxants (2.2%), and benzodiazepines (2.1%). CONCLUSIONS: A majority of crash-involved older adults were exposed to multiple PDI medications before and after MVC. A greater proportion of person-crashes were associated with an increased rather than decreased number of PDI medications. The reasons why clinicians refrain from stopping PDI medications following an MVC remain to be elucidated.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Riester MR, D'Amico AM, Khan MA, et al. Changes in the burden of medications that may impair driving among older adults before and after a motor vehicle crash. J Am Geriatr Soc. 2023. PMID: 37905738. doi:10.1111/jgs.18643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。